MELVILLE, N.Y.–(BUSINESS WIRE)–Responding to the growing need for dedicated ophthalmic image management software that is easy to use and can enhance office workflow, while also keeping security and compliance with CMS and HIPAA regulations in mind, C…
Category: Business
NovaBay Pharmaceuticals Signs Agreement with Nation’s Second Largest Independent Optometry Group, ALLDocs
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on commercializing and developing non-antibiotic antimicrobial products for the global eye care market, today announced that the company’s prescription daily eyelid and lash hygiene product Avenova™ will be marketed through ALLDocs Optometry Group, making the product available to the group’s optometrists. ALLDocs, also known as The Association of LensCrafters Leaseholding Doc
Anthem Foundation Impacting Blind and Visually Impaired People Nationwide
COLORADO SPRINGS, Colo.–(BUSINESS WIRE)–Anthem Foundation provides a $213,120 grant to the United States Association of Blind Athletes to support more than 500 blind and visually impaired adults in the National Fitness Challenge.
InSite Vision and Sun Pharma Enter into Merger Agreement
ALAMEDA, Calif.–(BUSINESS WIRE)–InSite Vision and Sun Pharma Enter Into Merger Agreement
Ocular Therapeutix Expands Its Board of Directors with the Appointment of Renowned Retinal Specialist Jeffrey S. Heier, M.D.
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Jeffrey S. Heier, M.D., a prominent retinal specialist, has been elected to Ocular’s Board of Directors. Dr. Heier is a leading retinal clinical researcher of new treatments for diseases of the back of the eye, including macular degeneration, diabetic macular edem
Research and Markets: Global Eyewear Market 2015-2019 – Increasing Use of Eyewear as Fashion Statement
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/j9b4zz/global_eyewear) has announced the addition of the “Global Eyewear Market 2015-2019” report to their offering. The global eyewear market to grow during the …
pSivida CEO to Present at Ladenburg Thalmann 2015 Healthcare Conference September 29, 2015
WATERTOWN, Mass.–(BUSINESS WIRE)–pSivida CEO to present at Ladenburg Thalmann 2015 Healthcare Conference September 29, 2015
Research and Markets: Pigment Glaucoma – Global Clinical Trials Review, H2, 2015
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/cfp9tk/pigment_glaucoma) has announced the addition of the “Pigment Glaucoma Global Clinical Trials Review, H2, 2015” report to their offering. “Pigment Glaucoma …
Research and Markets: Dry (Atrophic) Macular Degeneration Market – Global Clinical Trials Review, H2, 2015
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/h94frj/dry_atrophic) has announced the addition of the “Dry (Atrophic) Macular Degeneration Global Clinical Trials Review, H2, 2015” report to their offering. “Dr…
Research and Markets: Corneal Neovascularization – Global Clinical Trials Review, H2, 2015
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/xglzkh/corneal) has announced the addition of the “Corneal Neovascularization Global Clinical Trials Review, H2, 2015” report to their offering. Corneal Neovascul…
Samenvatting: Novaliq GmbH versterkt uitvoerend bestuur Oliver Schlüter en Hartmut Voss
HEIDELBERG, Germany–(BUSINESS WIRE)–Novaliq GmbH, een farmaceutisch bedrijf dat moeilijk oplosbare medicijnen omvormt tot effectieve oogheelkundige therapieën, heeft vandaag bekendgemaakt dat Oliver Schlüter het bedrijf versterkt als algemeen directeur en financieel bestuurder. Daarnaast benoemt Novaliq Hartmut Boss tot hoofd bedrijfszaken. Dr. Schlüter was eerder financieel directeur van CureVac, waar hij een groot aandeel had in de transformatie een zeventig werknemers tellend onderzoeksbed
pSivida Corp. Provides Company Update and Reports Fourth Quarter and FY 2015 Results
WATERTOWN, Mass.–(BUSINESS WIRE)–pSivida provides company update and reports fourth quarter and FY 2015 results
Research and Markets: Global Dry Eye Syndrome Market 2015-2019 with Alcon, Allergan, Otsuka Holdings & Santen Pharmaceuticals Dominating
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/kj2mjh/global_dry_eye) has announced the addition of the “Global Dry Eye Syndrome Market 2015-2019” report to their offering. The global dry eye syndrome market i…
Ophthotech Corporation to Present at the Morgan Stanley Global Healthcare Conference
NEW YORK–(BUSINESS WIRE)–Ophthotech announced that David R. Guyer, M.D., Chief Executive Officer and Chairman of the Board, will present an overview of the Company at the Morgan Stanley Global Healthcare Conference.
Research and Markets: 2015 Adaptive Optics Market by Component, End-User and Geography – Global Forecast to 2020 – Military & Defense Sector was the Largest Contributor
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/3vhsjc/adaptive_optics) has announced the addition of the “Adaptive Optics Market by Component, End-User and Geography – Global Forecast to 2020” report to their offering. The global adaptive optics market is expected to reach USD 7,666.4 Million by 2020, at a CAGR of 99.4% between 2015 and 2020 The military & defense sector was the largest contributor to the overall adaptive optics market, accounting
Aerie Pharmaceuticals and Ramot at Tel Aviv University Enter Research Collaboration
IRVINE, Calif. & TEL AVIV, Israel–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye, and Ramot at Tel Aviv University Ltd., Tel Aviv University’s technology transfer company, today announced a research collaboration and license agreement for a preclinical anti-beta amyloid small molecu
Research and Markets: Optical Coherence Tomography for Healthcare and Life Science: Technology and Market Trends
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/x3v2cr/optical_coherence) has announced the addition of the “Optical Coherence Tomography for Healthcare and Life Science: Technology and Market Trends” report to…
Síndrome de ojo seco: el simposio internacional de Dompé se centra en una nueva investigación para pacientes con necesidades no cubiertas
BARCELONA, España–(BUSINESS WIRE)–Rojez, irritación, picor, ardor o la sensación de tener algo bajo el párpado son los síntomas más comunes del síndrome de ojo seco, un problema cada vez más común asociado a factores relacionados con el entorno, los hábitos y el estilo de vida que llevan a una reducción de la lubricación ocular. El síndrome de ojo seco se subestima a menudo, pero puede tener consecuencias graves en la vista de los pacientes, sobre todo en su variante moderada y grave. Este se
InSite Vision Determines that an Unsolicited Offer from a Global Pharmaceutical Company to Acquire InSite for $0.35 per Share in Cash Constitutes a “Company Superior Proposal”
ALAMEDA, Calif.–(BUSINESS WIRE)–InSite Vision Determines that an Unsolicited Offer from a Global Pharmaceutical Company to Acquire InSite for $0.35 per Share in Cash Constitutes a “Company Superior Proposal”
Dry eye syndroom: een internationaal symposium van Dompé richt zich op nieuw onderzoek voor aanpak van onvervulde behoeften van patiënten
BARCELONA, Spanje–(BUSINESS WIRE)–Roodheid en irritatie, jeuk en verbranding van het oog en de sensatie van het hebben van een vreemde stof onder het ooglid zijn de meest voorkomende symptomen van het dry eye syndroom, een steeds vaker voorkomend probleem in verband met milieu-, gedrags- en leefstijlfactoren die leiden tot verminderde oculaire smering. Dry eye syndroom wordt vaak onderschat, maar kan aanzienlijke gevolgen hebben voor het gezichtsvermogen van patiënten, vooral in de matige en